I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.
4-Nitrophenyl bromoacetate is used as a haloacetamide
Richard A. Glennon.; Milt Titeler.; Mark Seggel.; Robert A. Lyon. N-Methyl derivatives of the 5-HT2 agonist 1-(4-bromo-2,5-dimethoxyphenyl)-2-aminopropane. J. Med. Chem. 1987, 30, (5), 930-932.
James R. Piper.; Anne G. Laseter.; John A. Montgomery. Synthesis of potential inhibitors of hypoxanthine-guanine phosphoribosyltransferase for testing as antiprotozoal agents. 1. 7-Substituted 6-oxopurines. J. Med. Chem. 1980, 23, (4), 357-364.
Reagent for introduction of the bromoacetyl group, compare 4-Nitrophenyl acetate, L00314.
Gefahrenhinweise (EU): H315-H318-H335
Causes skin irritation. Causes serious eye damage. May cause respiratory irritation.
Do not breathe dust/fume/gas/mist/vapours/spray. Obtain special instructions before use. Wear protective gloves. IF INHALED: Remove to fresh air and keep at rest in a position comfortable for breathing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.